• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Alternatively spliced tissue factor induces angiogenesis through integrin ligation.可变剪接的组织因子通过整合素连接诱导血管生成。
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19497-502. doi: 10.1073/pnas.0905325106. Epub 2009 Oct 29.
2
Splice variants of Tissue Factor and integrin-mediated signaling.组织因子和整合素介导的信号转导的剪接变体。
Thromb Res. 2012 May;129 Suppl 2:S34-7. doi: 10.1016/j.thromres.2012.02.027. Epub 2012 Mar 17.
3
Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.组织因子的剪接变体通过整合素介导的信号转导触发细胞黏附分子的表达,从而促进单核细胞-内皮细胞相互作用。
J Thromb Haemost. 2011 Oct;9(10):2087-96. doi: 10.1111/j.1538-7836.2011.04454.x.
4
Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes?
Hamostaseologie. 2010 Aug;30(3):144-9.
5
Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells.组织因子剪接异构体的过表达诱导鼠心肌细胞 HL-1 的促血管生成特性。
Circ J. 2011;75(5):1235-42. doi: 10.1253/circj.cj-10-0783. Epub 2011 Mar 7.
6
Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.可变剪接的组织因子在促进乳腺癌进展过程中与雌激素受体途径协同作用。
J Thromb Haemost. 2015 Sep;13(9):1683-93. doi: 10.1111/jth.13049. Epub 2015 Jul 31.
7
Expression of flTF and asTF splice variants in various cell strains and tissues.flTF 和 asTF 剪接变异体在各种细胞株和组织中的表达。
Mol Med Rep. 2019 Mar;19(3):2077-2086. doi: 10.3892/mmr.2019.9843. Epub 2019 Jan 10.
8
Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. 剪接组织因子以β1 整合素依赖的方式促进乳腺癌生长。
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11517-22. doi: 10.1073/pnas.1307100110. Epub 2013 Jun 25.
9
Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.可变剪接的组织因子通过激活缺氧诱导因子-1α和血管内皮生长因子信号通路促进斑块血管生成。
Circulation. 2014 Oct 7;130(15):1274-86. doi: 10.1161/CIRCULATIONAHA.114.006614. Epub 2014 Aug 12.
10
Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.缺氧诱导的人肺癌细胞中促血管生成组织因子表达的调控。
Oncol Rep. 2013 Jul;30(1):462-70. doi: 10.3892/or.2013.2413. Epub 2013 Apr 22.

引用本文的文献

1
Identification of the Interacting Domains Between Tissue Factor and β1-Integrin and the Signalling Properties of the Two Fibronectin-like Domains of Tissue Factor.组织因子与β1整合素相互作用结构域的鉴定以及组织因子两个纤连蛋白样结构域的信号特性
Cancers (Basel). 2025 Feb 14;17(4):644. doi: 10.3390/cancers17040644.
2
Activated Factor VII-Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer.活化凝血因子VII-抗凝血酶复合物,不同临床环境中组织因子相关通路的生物标志物:从心血管疾病到癌症的叙述性综述
Diagnostics (Basel). 2024 Aug 6;14(16):1711. doi: 10.3390/diagnostics14161711.
3
Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format.将抗组织因子抗体序列转化为嵌合抗原受体和双特异性 T 细胞衔接器形式。
Cancer Immunol Immunother. 2024 Aug 6;73(10):195. doi: 10.1007/s00262-024-03778-3.
4
First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma.针对可变剪接组织因子的首创人源化抗体增强了化疗在胰腺导管腺癌临床前模型中的抗转移疗效。
Int J Mol Sci. 2024 Feb 23;25(5):2580. doi: 10.3390/ijms25052580.
5
Hemostasis and endothelial functionality: the double face of coagulation factors.止血与血管内皮功能:凝血因子的双重作用。
Haematologica. 2024 Jul 1;109(7):2041-2048. doi: 10.3324/haematol.2022.282272.
6
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.通过联合 CD147 抑制与组织因子途径抑制剂靶向肿瘤细胞外囊泡以管理膀胱癌。
Cell Commun Signal. 2024 Feb 15;22(1):129. doi: 10.1186/s12964-024-01508-x.
7
Chitosan nanoparticle toxicity: A comprehensive literature review of and assessments for medical applications.壳聚糖纳米颗粒毒性:医学应用的体外和体内评估综合文献综述
Toxicol Rep. 2023 Jun 29;11:83-106. doi: 10.1016/j.toxrep.2023.06.012. eCollection 2023 Dec.
8
Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment.胰腺癌分泌蛋白:靶向其在肿瘤微环境中的功能
Cancers (Basel). 2023 Oct 1;15(19):4825. doi: 10.3390/cancers15194825.
9
The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis.组织因子在病理状态和血管生成信号通路中的作用
Curr Mol Med. 2024;24(9):1135-1151. doi: 10.2174/0115665240258746230919165935.
10
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.组织因子(凝血因子III):一种有望针对癌症进行靶向及重新靶向的潜在双刃剑分子。
Biomark Res. 2023 Jun 6;11(1):60. doi: 10.1186/s40364-023-00504-6.

本文引用的文献

1
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.表皮生长因子受体和上皮-间质转化对组织因子的调控:对肿瘤起始和血管生成的影响
Cancer Res. 2008 Dec 15;68(24):10068-76. doi: 10.1158/0008-5472.CAN-08-2067.
2
Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.蛋白酶激活受体(PAR)2而非PAR1的信号传导促进多瘤病毒中T抗原小鼠乳腺腺癌的发展。
Cancer Res. 2008 Sep 1;68(17):7219-27. doi: 10.1158/0008-5472.CAN-08-0419.
3
Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.人非小细胞肺癌组织中的组织因子表达模式表明血液血栓形成性增加和肿瘤转移。
Oncol Rep. 2008 Jul;20(1):123-8.
4
The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro.活化凝血因子VII-组织因子复合物在体外可诱导LOVO细胞中基质金属蛋白酶7的表达。
Int J Colorectal Dis. 2008 Oct;23(10):971-8. doi: 10.1007/s00384-008-0496-y. Epub 2008 Jun 12.
5
Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.血管内皮生长因子、Notch信号通路与转化生长因子-β在血管形态发生中的相互作用
Circ Res. 2008 Mar 28;102(6):637-52. doi: 10.1161/CIRCRESAHA.107.167171.
6
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.可变剪接的人组织因子在胰腺癌肿瘤模型中促进肿瘤生长和血管生成。
Thromb Res. 2007;120 Suppl 2:S13-21. doi: 10.1016/S0049-3848(07)70126-3.
7
Inhibition of tissue factor signaling suppresses tumor growth.抑制组织因子信号传导可抑制肿瘤生长。
Blood. 2008 Jan 1;111(1):190-9. doi: 10.1182/blood-2007-07-101048. Epub 2007 Sep 27.
8
Alternatively spliced human tissue factor (asHTF) is not pro-coagulant.可变剪接的人组织因子(asHTF)不具有促凝血作用。
Thromb Haemost. 2007 Jan;97(1):11-4.
9
Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.胰腺腺癌中组织因子的表达与凝血激活相关。
World J Gastroenterol. 2006 Aug 14;12(30):4843-9. doi: 10.3748/wjg.v12.i30.4843.
10
Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis.可变剪接的组织因子:止血谜题中一个前所未知的部分。
Trends Cardiovasc Med. 2006 Jul;16(5):177-82. doi: 10.1016/j.tcm.2006.03.005.

可变剪接的组织因子通过整合素连接诱导血管生成。

Alternatively spliced tissue factor induces angiogenesis through integrin ligation.

作者信息

van den Berg Y W, van den Hengel L G, Myers H R, Ayachi O, Jordanova E, Ruf W, Spek C A, Reitsma P H, Bogdanov V Y, Versteeg H H

机构信息

The Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

出版信息

Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19497-502. doi: 10.1073/pnas.0905325106. Epub 2009 Oct 29.

DOI:10.1073/pnas.0905325106
PMID:19875693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2780792/
Abstract

The initiator of coagulation, full-length tissue factor (flTF), in complex with factor VIIa, influences angiogenesis through PAR-2. Recently, an alternatively spliced variant of TF (asTF) was discovered, in which part of the TF extracellular domain, the transmembrane, and cytoplasmic domains are replaced by a unique C terminus. Subcutaneous tumors produced by asTF-secreting cells revealed increased angiogenesis, but it remained unclear if and how angiogenesis is regulated by asTF. Here, we show that asTF enhances angiogenesis in matrigel plugs in mice, whereas a soluble form of flTF only modestly enhances angiogenesis. asTF dose-dependently upregulates angiogenesis ex vivo independent of either PAR-2 or VIIa. Rather, asTF was found to ligate integrins, resulting in downstream signaling. asTF-alphaVbeta3 integrin interaction induces endothelial cell migration, whereas asTF-dependent formation of capillaries in vitro is dependent on alpha6beta1 integrin. Finally, asTF-dependent aortic sprouting is sensitive to beta1 and beta3 integrin blockade and a TF-antibody that disrupts asTF-integrin interaction. We conclude that asTF, unlike flTF, does not affect angiogenesis via PAR-dependent pathways but relies on integrin ligation. These findings indicate that asTF may serve as a target to prevent pathological angiogenesis.

摘要

凝血起始因子全长组织因子(flTF)与因子VIIa形成复合物,通过蛋白酶激活受体-2(PAR-2)影响血管生成。最近,发现了组织因子(TF)的一种选择性剪接变体(asTF),其中TF细胞外结构域的一部分、跨膜结构域和细胞质结构域被一个独特的C末端所取代。由分泌asTF的细胞产生的皮下肿瘤显示血管生成增加,但asTF是否以及如何调节血管生成仍不清楚。在此,我们表明asTF可增强小鼠基质胶塞中的血管生成,而可溶性形式的flTF仅适度增强血管生成。asTF在体外剂量依赖性地上调血管生成,且不依赖于PAR-2或VIIa。相反,发现asTF可与整合素结合,导致下游信号传导。asTF与αVβ3整合素的相互作用诱导内皮细胞迁移,而asTF依赖的体外毛细血管形成则依赖于α6β1整合素。最后,asTF依赖的主动脉芽生对β1和β3整合素阻断以及破坏asTF-整合素相互作用的TF抗体敏感。我们得出结论,与flTF不同,asTF不通过PAR依赖途径影响血管生成,而是依赖于整合素结合。这些发现表明asTF可能作为预防病理性血管生成的靶点。